Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Reports Solid 2024 Interim Results 2024-08-21 23:46
Waterdrop Inc. to Report Second Quarter 2024 Financial Results on September 4, 2024 2024-08-21 19:45
INTERNATIONAL COLLABORATION AIMS TO COMBAT DIABETES EPIDEMIC IN THE SOUTH PACIFIC 2024-08-21 14:35
GenScript Launches Global Philanthropy Platform: The GenTeer Program 2024-08-21 09:40
Coway Launches First-Ever Customized Filter Line for Top-Selling Airmega Air Purifier Models 2024-08-21 00:00
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth 2024-08-20 23:05
UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions 2024-08-19 21:00
CARsgen Announces Enrollment Completion in China GC/GEJ Pivotal Phase II Clinical Trial of the First-in-class Claudin18.2 CAR T (Satri-cel) 2024-08-19 20:50
Health In Tech Partners with NovaNet and Tall Tree to Host Webinar on the Latest Strategies for Personalizing Client Health Coverage 2024-08-19 20:30
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 2024-08-19 20:00
2024 World Life Science Conference Scheduled for October 19 in Hainan, China 2024-08-18 20:20
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts 2024-08-16 18:00
Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched 2024-08-16 06:00
Vimgreen Completes Enrollment of Its Phase 2 Clinical Trial Evaluating VG081821AC for the Treatment of Parkinson's Disease 2024-08-15 21:37
Zepp Health Partners with Wild.AI to Offer Groundbreaking Women's Wellness App on Amazfit Smartwatches 2024-08-15 21:00
Xinhua Silk Road: Italy-based Salov, subsidiary of China's Bright Food Group, promotes olive oil culture through talent dev't programs 2024-08-15 15:54
Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC 2024-08-15 07:30
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" 2024-08-13 20:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China's NMPA 2024-08-12 22:00
1 18 19 20 21 22 800